Variant report
Variant | nsv900853 |
---|---|
Chromosome Location | chr13:89824076-89873873 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:61)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:16)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr13:89856664-89857107 | ECC-1 | luminal epithelium: | n/a | chr13:89856807-89856824 |
2 | CEBPB | chr13:89870206-89870527 | HepG2 | liver: | n/a | chr13:89870358-89870367 chr13:89870358-89870369 chr13:89870356-89870367 |
3 | CEBPB | chr13:89856691-89857129 | ECC-1 | luminal epithelium: | n/a | chr13:89856807-89856824 |
4 | CTCF | chr13:89873440-89873590 | WERI-Rb-1 | eye: | n/a | n/a |
5 | E2F4 | chr13:89856319-89856519 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | E2F4 | chr13:89862284-89862740 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | E2F4 | chr13:89858454-89858750 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | EP300 | chr13:89856582-89857113 | ECC-1 | luminal epithelium: | n/a | chr13:89856961-89856971 |
9 | EP300 | chr13:89856527-89857222 | ECC-1 | luminal epithelium: | n/a | chr13:89856961-89856971 |
10 | EP300 | chr13:89834322-89834358 | Hela-S3 | cervix: | n/a | n/a |
11 | FOS | chr13:89851357-89851651 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr13:89851249-89851730 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOXA1 | chr13:89864463-89864714 | T-47D | breast: | n/a | chr13:89864608-89864623 |
14 | FOXA1 | chr13:89864485-89864812 | T-47D | breast: | n/a | chr13:89864608-89864623 |
15 | FOXM1 | chr13:89856497-89857158 | ECC-1 | luminal epithelium: | n/a | n/a |
16 | FOXM1 | chr13:89856553-89857286 | ECC-1 | luminal epithelium: | n/a | n/a |
17 | GATA3 | chr13:89864459-89864800 | T-47D | breast: | n/a | chr13:89864633-89864641 |
18 | GATA3 | chr13:89864404-89864735 | T-47D | breast: | n/a | chr13:89864633-89864641 |
19 | GATA3 | chr13:89856112-89856312 | SH-SY5Y | brain: | n/a | n/a |
20 | JUN | chr13:89857089-89857287 | HepG2 | liver: | n/a | chr13:89857197-89857210 |
21 | JUND | chr13:89857032-89857301 | HepG2 | liver: | n/a | n/a |
22 | JUND | chr13:89867705-89867868 | HepG2 | liver: | n/a | chr13:89867736-89867747 |
23 | KAP1 | chr13:89873637-89874352 | HEK293 | kidney: | n/a | n/a |
24 | MAFK | chr13:89851718-89851856 | HepG2 | liver: | n/a | n/a |
25 | MAFK | chr13:89853726-89853937 | HepG2 | liver: | n/a | chr13:89853813-89853830 chr13:89853822-89853833 chr13:89853822-89853833 chr13:89853817-89853832 chr13:89853821-89853832 |
26 | MAFK | chr13:89853756-89853939 | HepG2 | liver: | n/a | chr13:89853813-89853830 chr13:89853822-89853833 chr13:89853822-89853833 chr13:89853817-89853832 chr13:89853821-89853832 |
27 | MAX | chr13:89858282-89858495 | NB4 | blood: | n/a | n/a |
28 | MAZ | chr13:89861231-89861341 | HepG2 | liver: | n/a | n/a |
29 | NFIC | chr13:89856547-89857166 | ECC-1 | luminal epithelium: | n/a | n/a |
30 | NFYB | chr13:89866289-89866341 | GM12878 | blood: | n/a | n/a |
31 | POLR2A | chr13:89833417-89833432 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr13:89858492-89858622 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr13:89850638-89850752 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | POLR2A | chr13:89870137-89870412 | SK-N-MC | brain: | n/a | n/a |
35 | POLR2A | chr13:89867011-89867052 | K562 | blood: | n/a | n/a |
36 | POLR2A | chr13:89859807-89859866 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr13:89868853-89869050 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr13:89866338-89866927 | SK-N-MC | brain: | n/a | n/a |
39 | POLR2A | chr13:89864518-89864879 | SK-N-MC | brain: | n/a | n/a |
40 | POLR2A | chr13:89851045-89851240 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr13:89857290-89857485 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr13:89831063-89831184 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | POLR2A | chr13:89852658-89852736 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | RAD21 | chr13:89838227-89838477 | H1-hESC | embryonic stem cell: | n/a | n/a |
45 | SETDB1 | chr13:89873562-89874441 | U2OS | brain: | n/a | n/a |
46 | SPI1 | chr13:89859937-89860313 | HL-60 | blood: | n/a | chr13:89860091-89860104 chr13:89860095-89860102 chr13:89860094-89860103 chr13:89860092-89860105 |
47 | STAT3 | chr13:89840596-89840873 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | STAT3 | chr13:89832842-89832864 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr13:89852995-89853195 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chr13:89831051-89831200 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:89843854..89844646-chr17:66927017..66927781,2 | MCF-7 | breast: |
(count:16 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLITRK6-10 | chr13:89872788-89872813 | ENSG00000232225.2 |
2 | lnc-SLITRK6-10 | chr13:89868228-89868395 | ENSG00000232225.2 |
3 | lnc-SLITRK6-10 | chr13:89871825-89871963 | ENSG00000232225.2 |
4 | lnc-SLITRK6-10 | chr13:89872788-89872813 | ENSG00000232225.2 |
5 | lnc-SLITRK6-10 | chr13:89867101-89867581 | XLOC_010684 |
6 | lnc-SLITRK6-10 | chr13:89870489-89870549 | XLOC_010684 |
7 | lnc-SLITRK6-10 | chr13:89867150-89867581 | XLOC_010684 |
8 | lnc-SLITRK6-10 | chr13:89868228-89868395 | XLOC_010684 |
9 | lnc-SLITRK6-10 | chr13:89872788-89872813 | XLOC_010684 |
10 | lnc-SLITRK6-10 | chr13:89871826-89871963 | XLOC_010684 |
11 | lnc-SLITRK6-10 | chr13:89867101-89867581 | ENSG00000232225.2 |
12 | lnc-SLITRK6-10 | chr13:89870489-89870548 | ENSG00000232225.2 |
13 | lnc-SLITRK6-10 | chr13:89870489-89870548 | ENSG00000232225.2 |
14 | lnc-SLITRK6-10 | chr13:89870489-89870549 | XLOC_010684 |
15 | lnc-SLITRK6-10 | chr13:89867150-89867581 | ENSG00000232225.2 |
16 | lnc-SLITRK6-10 | chr13:89872788-89872813 | XLOC_010684 |
No data |
No data |
Variant related genes | Relation type |
---|---|
LINC01047 | TF binding region |
RTKN | miRNA target sites |
RTCD1 | miRNA target sites |
RTF1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs57207757 | chr13:89850809-89850810 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574914185 | chr13:89850817-89850818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs58587355 | chr13:89850825-89850826 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs9555857 | chr13:89850852-89850853 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs527885801 | chr13:89850873-89850874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559500857 | chr13:89850874-89850875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189018728 | chr13:89850880-89850881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191878506 | chr13:89850900-89850901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111694221 | chr13:89850941-89850942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369561665 | chr13:89851037-89851038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140689338 | chr13:89851042-89851043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549633274 | chr13:89851044-89851045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9560248 | chr13:89851091-89851092 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs9560249 | chr13:89851094-89851095 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs9522457 | chr13:89851096-89851097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184261835 | chr13:89851113-89851114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9560250 | chr13:89851128-89851129 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs117129877 | chr13:89851137-89851138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576177554 | chr13:89851177-89851178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569893531 | chr13:89851205-89851206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143036562 | chr13:89851214-89851215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556415666 | chr13:89851224-89851225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574875697 | chr13:89851272-89851273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542290836 | chr13:89851292-89851293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144727329 | chr13:89851372-89851373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188546051 | chr13:89851384-89851385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546195784 | chr13:89851385-89851386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80202942 | chr13:89851399-89851400 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148545555 | chr13:89851410-89851411 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549834509 | chr13:89851415-89851416 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561490232 | chr13:89851436-89851437 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113599774 | chr13:89851439-89851440 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs180942310 | chr13:89851442-89851443 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11843359 | chr13:89851480-89851481 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs565741177 | chr13:89851517-89851518 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10459312 | chr13:89851525-89851526 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs185769034 | chr13:89851572-89851573 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565579501 | chr13:89851577-89851578 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10459313 | chr13:89851578-89851579 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs190798118 | chr13:89851591-89851592 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557602731 | chr13:89851643-89851644 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569816496 | chr13:89851646-89851647 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536889554 | chr13:89851670-89851671 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544566475 | chr13:89851691-89851692 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556616348 | chr13:89851701-89851702 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs568519771 | chr13:89851751-89851752 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535962505 | chr13:89851786-89851787 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9560251 | chr13:89851873-89851874 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs536823805 | chr13:89851875-89851876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9301544 | chr13:89851942-89851943 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:89850800-89851200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr13:89850800-89851400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr13:89850800-89851400 | Enhancers | HMEC | breast |
4 | chr13:89850800-89851400 | Enhancers | NHEK | skin |
5 | chr13:89850800-89852400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr13:89851200-89852200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr13:89851400-89851800 | Flanking Active TSS | NHEK | skin |
8 | chr13:89851400-89852000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr13:89851800-89852800 | Enhancers | NHEK | skin |
10 | chr13:89852000-89852200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr13:89852200-89852800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr13:89852800-89857200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr13:89857200-89858000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr13:89858000-89858600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr13:89858000-89858600 | Enhancers | Fetal Lung | lung |
16 | chr13:89858200-89858600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr13:89860400-89861200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr13:89865800-89867600 | Enhancers | Fetal Lung | lung |
19 | chr13:89866600-89867600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
20 | chr13:89873400-89875000 | ZNF genes & repeats | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |